HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Priya S Kishnani Selected Research

Thrombocytopenia (Thrombopenia)

9/2017Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy.
3/2013Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Priya S Kishnani Research Topics

Disease

146Glycogen Storage Disease Type II (Pompe's Disease)
02/2024 - 08/2005
21Down Syndrome (Down's Syndrome)
10/2023 - 01/2003
16Hypophosphatasia
03/2024 - 01/2016
16Glycogen Storage Disease (Glycogenosis)
09/2023 - 07/2010
13Disease Progression
01/2023 - 12/2011
12Cardiomyopathies (Cardiomyopathy)
07/2023 - 05/2007
12Gaucher Disease (Gaucher's Disease)
05/2023 - 03/2013
11Muscular Diseases (Myopathy)
07/2023 - 05/2006
11Glycogen Storage Disease Type III (Cori's Disease)
12/2022 - 03/2007
9Muscle Weakness
12/2021 - 12/2006
8Fibrosis (Cirrhosis)
06/2022 - 03/2007
7Pain (Aches)
12/2023 - 01/2017
7Glycogen Storage Disease IIIA
12/2022 - 11/2012
6Hypoglycemia (Reactive Hypoglycemia)
07/2023 - 04/2010
6Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 06/2014
6Glycogen Storage Disease Type Ix
01/2021 - 12/2011
5Glycogen Storage Disease Type I
09/2023 - 04/2010
5Lysosomal Storage Diseases (Lysosomal Storage Disease)
12/2022 - 12/2006
5Hepatomegaly
06/2022 - 01/2017
5Liver Diseases (Liver Disease)
06/2022 - 03/2007
4Liver Cell Adenoma (Hepatocellular Adenoma)
09/2023 - 11/2007
4Glycogen Storage Disease IB
01/2023 - 09/2012
4Glycogen Storage Disease Type IV (Andersen's Disease)
01/2023 - 01/2016
4Metabolic Bone Diseases (Osteopenia)
01/2021 - 10/2016
4Infections
10/2020 - 09/2009
4Neoplasms (Cancer)
01/2020 - 08/2006
4Hepatorenal form of glycogen storage disease
11/2018 - 11/2007
3Fatigue
03/2024 - 01/2022
3Adenoma (Adenomas)
07/2023 - 11/2007
3Respiratory Insufficiency (Respiratory Failure)
01/2023 - 01/2017
3Rare Diseases (Rare Disease)
01/2023 - 01/2016
3Alzheimer Disease (Alzheimer's Disease)
04/2021 - 12/2006
3Body Weight (Weight, Body)
01/2021 - 04/2010
3Anemia
01/2020 - 09/2012
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 04/2010
3Cardiac Arrhythmias (Arrythmia)
01/2015 - 08/2007
3Vacuolar myopathy
11/2014 - 01/2010
2Headache (Headaches)
12/2023 - 12/2021
2Carcinoma (Carcinomatosis)
07/2023 - 11/2007
2Overweight
01/2023 - 01/2023
2Neutropenia
01/2023 - 01/2019
2Myalgia
01/2023 - 12/2021
2Metabolic Diseases (Metabolic Disease)
01/2021 - 11/2020
2Congenital Abnormalities (Deformity)
01/2021 - 02/2019

Drug/Important Bio-Agent (IBA)

67AcidsIBA
01/2024 - 08/2003
59human GAA protein (Myozyme)FDA Link
01/2024 - 08/2005
53GlycogenIBA
07/2023 - 12/2006
41EnzymesIBA
09/2023 - 01/2003
37GlucosidasesIBA
01/2024 - 12/2010
30alpha-Glucosidases (Acid Maltase)IBA
01/2023 - 05/2006
15N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
03/2024 - 01/2016
15Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2005
8Alkaline PhosphataseIBA
03/2024 - 12/2016
8AntibodiesIBA
07/2019 - 01/2009
7asfotase alfaIBA
03/2024 - 01/2017
6glucose tetrasaccharideIBA
03/2021 - 08/2005
6Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 08/2006
6Donepezil (Aricept)FDA LinkGeneric
12/2010 - 01/2003
5Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
09/2023 - 04/2008
5Glucose (Dextrose)FDA LinkGeneric
07/2023 - 04/2008
5Liver GlycogenIBA
06/2022 - 11/2012
5Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 04/2012
5Rituximab (Mabthera)FDA Link
01/2021 - 04/2012
5Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA
09/2020 - 03/2007
5Hemoglobins (Hemoglobin)IBA
01/2020 - 09/2012
5Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2011
4Immunoglobulin G (IgG)IBA
01/2024 - 02/2010
4eliglustatIBA
01/2019 - 02/2016
3miglustat (Zavesca)FDA Link
02/2024 - 12/2021
3Bortezomib (Velcade)FDA Link
01/2024 - 02/2013
31,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA
01/2023 - 01/2016
3Creatine Kinase (Creatine Phosphokinase)IBA
12/2022 - 02/2016
3DextrinsIBA
03/2021 - 03/2007
3IsoenzymesIBA
01/2021 - 05/2006
3Albuterol (Salbutamol)FDA LinkGeneric
01/2020 - 02/2012
3Transaminases (Aminotransferases)IBA
12/2019 - 01/2017
3Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA
01/2019 - 03/2014
3ClenbuterolIBA
01/2018 - 02/2012
3imigluceraseFDA Link
09/2017 - 03/2013
3Cholinergic Agents (Cholinergics)IBA
01/2016 - 12/2006
3Rivastigmine (Exelon)FDA LinkGeneric
01/2016 - 12/2006
2Alanine Transaminase (SGPT)IBA
09/2023 - 12/2022
2C-Reactive ProteinIBA
01/2023 - 09/2012
2pullulanase (limit dextrinase)IBA
12/2022 - 09/2020
2LipidsIBA
11/2022 - 01/2020
2Glucosylceramides (Glucocerebrosides)IBA
06/2021 - 02/2016
2sphingosyl beta-glucosideIBA
06/2021 - 02/2016
2GadoliniumIBA
02/2021 - 12/2010
2PyridoxalIBA
01/2021 - 01/2019
2diphosphoric acid (pyrophosphoric acid)IBA
01/2021 - 01/2019

Therapy/Procedure

99Enzyme Replacement Therapy
01/2024 - 08/2005
44Therapeutics
02/2024 - 05/2006
6Mechanical Ventilators (Ventilator)
07/2019 - 05/2006
4Immunomodulation
01/2024 - 04/2012
4Breathing Exercises
11/2020 - 01/2014
4Enzyme Therapy
01/2017 - 11/2007
3Physical Therapy Modalities (Physical Therapy Technique)
01/2021 - 02/2012
3Liver Transplantation
01/2019 - 11/2007
2Diet Therapy (Therapy, Diet)
12/2021 - 11/2007
2Immunotherapy
01/2021 - 01/2019